The latest news release from Immune Response BioPharma includes the following statement, "I believe we are close to receiving funding and support from a prominent businessman and we will move forward building a dynamic pharmaceutical company to save lives. Those who wait to partner with IRBP and wait to collaborate including big pharma will lose out” Mr. Buswell COO.
Wouldn't it be interesting if the prominent businessman and financing were to come from Kevin Kimberlin and the good folks at Spencer Trask. The same folks who started Immune Response Corporation later Orchestra Therapeutics and then manipulated the stock into the ground, purchased all the research property rights and then abandoned them so that a new company called Immune Response BioPharma could reform using the same research and technology leaving all the old investors behind.
No comments:
Post a Comment